State Street’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-558,178
| Closed | -$55.8K | – | 4274 |
|
|
2025
Q4 | $55.8K | Buy |
558,178
+39,660
| +8% | +$25.2K | ﹤0.01% | 4137 |
|
|
2025
Q3 | $314K | Buy |
518,518
+166,141
| +47% | +$78.3K | ﹤0.01% | 3769 |
|
|
2025
Q2 | $110K | Sell |
352,377
-1,598,532
| -82% | -$618K | ﹤0.01% | 3961 |
|
|
2025
Q1 | $954K | Sell |
1,950,909
-115,427
| -6% | -$68K | ﹤0.01% | 3438 |
|
|
2024
Q4 | $1.77M | Sell |
2,066,336
-1,628,271
| -44% | -$10.2M | ﹤0.01% | 3356 |
|
|
2024
Q3 | $31.4M | Buy |
3,694,607
+2,038,724
| +123% | +$12M | ﹤0.01% | 1943 |
|
|
2024
Q2 | $7.73M | Buy |
1,655,883
+1,449,214
| +701% | +$6.86M | ﹤0.01% | 2718 |
|
|
2024
Q1 | $1.41M | Buy |
206,669
+66,000
| +47% | +$296K | ﹤0.01% | 3387 |
|
|
2023
Q4 | $471K | Buy |
140,669
+3,400
| +2% | +$8.46K | ﹤0.01% | 3653 |
|
|
2023
Q3 | $342K | Buy |
137,269
+74,539
| +119% | +$123K | ﹤0.01% | 3769 |
|
|
2023
Q2 | $80.3K | Sell |
62,730
-31,685
| -34% | -$42K | ﹤0.01% | 4290 |
|
|
2023
Q1 | $76.6K | Hold |
94,415
| – | – | ﹤0.01% | 4397 |
|
|
2022
Q4 | $71.8K | Hold |
94,415
| – | – | ﹤0.01% | 4463 |
|
|
2022
Q3 | $88K | Hold |
94,415
| – | – | ﹤0.01% | 4503 |
|
|
2022
Q2 | $90K | Sell |
94,415
-331,989
| -78% | -$544K | ﹤0.01% | 4568 |
|
|
2022
Q1 | $900K | Buy |
426,404
+84,753
| +25% | +$227K | ﹤0.01% | 3845 |
|
|
2021
Q4 | $3.06M | Buy |
341,651
+27,700
| +9% | +$364K | ﹤0.01% | 3482 |
|
|
2021
Q3 | $5.21M | Buy |
313,951
+29,382
| +10% | +$507K | ﹤0.01% | 3218 |
|
|
2021
Q2 | $5.91M | Buy |
284,569
+44,054
| +18% | +$834K | ﹤0.01% | 3171 |
|
|
2021
Q1 | $4.51M | Buy |
240,515
+6,680
| +3% | +$144K | ﹤0.01% | 3095 |
|
|
2020
Q4 | $5.15M | Sell |
233,835
-5,210
| -2% | -$108K | ﹤0.01% | 2940 |
|
|
2020
Q3 | $4.96M | Sell |
239,045
-3,481
| -1% | -$90.5K | ﹤0.01% | 2789 |
|
|
2020
Q2 | $8.77M | Buy |
242,526
+103,482
| +74% | +$4.33M | ﹤0.01% | 2493 |
|
|
2020
Q1 | $4.54M | Buy |
139,044
+55,212
| +66% | +$2.23M | ﹤0.01% | 2673 |
|
|
2019
Q4 | $2.29M | Buy |
83,832
+73,029
| +676% | +$1.25M | ﹤0.01% | 3199 |
|
|
2019
Q3 | $119K | Buy |
+10,803
| New | +$102K | ﹤0.01% | 3655 |
|
State Street's APLT Position: Q1 2026 in Review
State Street sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 558,178 shares — an estimated $55.8K sold.
State Street first reported a position in APLT in Q3 2019 and held it in 26 quarters. The position peaked at $31.4M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- State Street reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- State Street sold 558,178 Applied Therapeutics shares in Q1 2026, an estimated $55.8K.
- State Street first reported a position in Applied Therapeutics in Q3 2019 and held it in 26 quarters.
- State Street's Applied Therapeutics position peaked at $31.4M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.